Eliem Therapeutics Inc (ELYM) stock is down -19.47% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ELYM stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 11. ELYM's rank also includes a long-term technical score of 18. ELYM has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ELYM!